Listening to patients is no longer a “nice to have” for life sciences companies—it is a strategic necessity that can ...
Orca Bio has disclosed $250 million in funding, flooding its balance sheet with cash to buoy preparations for the ...
Five months ago, J&J also revealed its plan to spend $2 billion over the next 10 years to operate a 160,000-square-foot ...
As Novartis turns the calendar on a new year, the Swiss drugmaker is elaborating further on plans for the $23 billion U.S.
Early launch numbers of Brinsupri are so strong that Insmed couldn’t wait for the J.P. Morgan Healthcare Conference to share ...
After a turbulent 2025, the biopharma industry is heading into the new year with major questions still unresolved. | In this ...
In the past three weeks, a flurry of licensing deals with Chinese biotechs were announced featuring AbbVie, AstraZeneca, ...
With a lioness-themed rebrand tied to its latest buy, Athira Pharma is roaring into the new year under its second new moniker. | The LeonaBio rebrand comes from the name Leona, which means lioness ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback